METHOD FOR ASSESSING THE RISK OF HOSPITAL MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROME FOLLOWING A PERCUTANEOUS CORONARY INTERVENTION Russian patent published in 2020 - IPC A61B5/00 G01N33/48 

FIELD: medicine; cardiology.

SUBSTANCE: degree of comorbidity (K9) is determined. That is ensured by detecting presence of diabetes mellitus, atrial fibrillation, previous history of stroke, arterial hypertension, obesity, peripheral atherosclerosis, thrombocytopenia, anemia, chronic kidney disease, which determine glomerular filtration rate by the formula CKD-EPI less than 60 ml/min/1.73 m². Based on the number of detected conditions, K9=1 is assigned if the patient has one of the transferred conditions; K9=2, if patient has 2 or 3 conditions; K9=3, if patient has 4 or more conditions. Besides, the risk level is determined on the GRACE ACS Risk model (G) scale, if the score is less than 102, then G=0 is assigned, if from 103 to 149—G=1, if score is 150 and higher, then G=2. That is followed by calculating the probable risk (R) according to the original formula. Based on the predicted onset of the lethal outcome during hospitalization: if R=0, the risk is considered to be minimum, R=2—low risk, R=3—high risk, R=4—extreme risk, R=6—risk "beyond limit".

EFFECT: method enables providing the accurate prediction of the lethal outcome at the hospital stage and identifying the categories of patients who are shown the post-percutaneous coronary intervention observation.

1 cl, 2 dwg, 3 tbl, 1 ex